Table 3.
Median (IQR) PCL Scores by Patient Characteristica
| Variable | PCL score median (IQR) |
|---|---|
| Demographics | |
| Survey agea | |
| Young (≤58.7) | 29.0 (22.0–40.5) |
| Old (>58.7) | 25.0 (21.0–34.0) |
| Gender | |
| Male | 24.0 (20.0–32.0) |
| Female | 28.0 (21.0–36.0) |
| White | |
| Yes | 25.0 (21.0–33.6) |
| No | 28.0 (21.0–36.0) |
| Private/commercial insurance (primary insurance) | |
| Yes | 23.0 (20.0–30.0) |
| No | 29.0 (22.5–39.5) |
| Income | |
| Less than $10,000 | 32.0 (22.0–45.7) |
| $10–24,999 | 27.0 (21.0–40.0) |
| $25–49,999 | 28.0 (21.0–32.0) |
| $50–74,999 | 26.0 (23.0–36.0) |
| $75–99,999 | 23.0 (20.5–29.0) |
| $100–149,999 | 20.5 (18.0–28.5) |
| More than $150,000 | 21.0 (21.0–26.0) |
| Education | |
| Some HS or less | 28.5 (20.0–33.3) |
| HS degree or some college | 25.0 (21.0–34.0) |
| 4-year college or grad school | 24.5 (21.0–35.0) |
| Married or engaged | |
| Yes | 24.0 (20.0–30.0) |
| No | 29.0 (22.0–42.0) |
| History of traumatic event ever in life | |
| Yes | 28.0 (21.0–36.0) |
| No | 22.0 (19.0–30.0) |
| Pre-/peri-transplant characteristics | |
| Pre-transplant Diagnosis | |
| COPD | 27.0 (21.0–37.0) |
| Cystic fibrosis | 26.5 (21.5–41.5) |
| Idiopathic pulmonary fibrosis | 24.0 (20.5–29.0) |
| PAH | 30.0 (25.0–42.0) |
| Other | 27.0 (20.0–36.0) |
| Days on waitlista | |
| ≤88.5 | 25.0 (21.0–32.0) |
| >88.5 | 26.0 (20.5–36.0) |
| Pulmonary function tests | |
| FVC, % predicteda | |
| ≤48.5 | 24.0 (20.0–35.0) |
| >48.5 | 26.0 (21.0–32.5) |
| FEV1, % predicteda | |
| ≤27 | 25.5 (20.5–36.5) |
| >27 | 25.0 (21.0–32.0) |
| Median most recent oxygen requirement prior to transplant, liters/min (IQR)a | |
| ≤3 | 26.0 (20.0–34.0) |
| >3 | 25.0 (21.0–33.0) |
| Six-minute walk test, feeta | |
| ≤1,057.5 | 25.5 (21.0–34.0) |
| >1,057.5 | 25.0 (21.0–34.0) |
| Transplant type | |
| Bilateral | 27.0 (21.0–34.0) |
| Unilateral | 23.0 (20.5–33.6) |
| Post-transplant characteristics | |
| Pulmonary function tests | |
| FVC, % predicteda | |
| ≤73 | 26.0 (22.0–36.0) |
| >73 | 24.0 (19.5–31.5) |
| FEV1, % predicteda | |
| ≤69 | 26.0 (22.0–36.0) |
| >69 | 24.0 (19.0–31.0) |
| Time since transplant, yearsa | |
| ≤2.4 | 28.0 (21.0–34.0) |
| >2.4 | 24.0 (20.0–34.0) |
| Current supplemental oxygen use | |
| Yes | 25.0 (22.0–46.0) |
| No | 25.0 (20.0–32.5) |
| Acute cellular rejection | |
| Yes | 28.0 (22.0–40.0) |
| No | 24.5 (20.0–32.0) |
| Bronchiolitis obliterans syndrome | |
| Yes | 30.0 (21.5–42.9) |
| No | 24.0 (20.0–32.0) |
FEV1, forced expiratory volume in 1 second; FVC, forced vital capacity; PAH, pulmonary arterial hypertension.
a
Continuous variables were dichotomized at their median for descriptive purposes only. They were analyzed as continuous variables